89Zr

You have access
Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
Philipp Diebolder, Cedric Mpoy, Jalen Scott, Truc T. Huynh, Ryan Fields, Dirk Spitzer, Nilantha Bandara and Buck E. Rogers

Journal of Nuclear Medicine January 1, 2021, 62 (1) 137-143; DOI: https://doi.org/10.2967/jnumed.120.249557
You have access
Light-Induced Radiosynthesis of ⁸⁹Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor
Simon Klingler, Rachael Fay and Jason P. Holland

Journal of Nuclear Medicine July 1, 2020, 61 (7) 1072-1078; DOI: https://doi.org/10.2967/jnumed.119.237180
You have access
⁸⁹Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber and Marc C. Huisman

Journal of Nuclear Medicine December 1, 2019, 60 (12) 1825-1832; DOI: https://doi.org/10.2967/jnumed.118.224568
You have access
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using ⁸⁹Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
Jorge A. Carrasquillo, Bernard M. Fine, Neeta Pandit-Taskar, Steven M. Larson, Stephen E. Fleming, Josef J. Fox, Sarah M. Cheal, Joseph A. O’Donoghue, Shutian Ruan, Govind Ragupathi, Serge K. Lyashchenko, John L. Humm, Howard I. Scher, Mithat Gönen, Simon P. Williams, Daniel C. Danila and Michael J. Morris

Journal of Nuclear Medicine November 1, 2019, 60 (11) 1517-1523; DOI: https://doi.org/10.2967/jnumed.118.222844
You have access
Fully Automated ⁸⁹Zr Labeling and Purification of Antibodies
Alex J. Poot, Kevin W.A. Adamzek, Albert D. Windhorst, Maria J.W.D. Vosjan, Saskia Kropf, Hans-Jurgen Wester, Guus A.M.S. van Dongen and Danielle J. Vugts

Journal of Nuclear Medicine May 1, 2019, 60 (5) 691-695; DOI: https://doi.org/10.2967/jnumed.118.217158
Open Access
Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
Thomas A. Burley, Chiara Da Pieve, Carlos D. Martins, Daniela M. Ciobota, Louis Allott, Wim J.G Oyen, Kevin J. Harrington, Graham Smith and Gabriela Kramer-Marek

Journal of Nuclear Medicine March 1, 2019, 60 (3) 353-361; DOI: https://doi.org/10.2967/jnumed.118.216069
You have access
An Overview of PET Radiochemistry, Part 2: Radiometals
Marie Brandt, Jens Cardinale, Margaret L. Aulsebrook, Gilles Gasser and Thomas L. Mindt

Journal of Nuclear Medicine October 1, 2018, 59 (10) 1500-1506; DOI: https://doi.org/10.2967/jnumed.117.190801
You have access
In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody–Drug Conjugates: Taking Advantage of Dual Labeling with ^195mPt and ⁸⁹Zr
Joey A. Muns, Veronica Montserrat, Hendrik-Jan Houthoff, Karlijn Codée-van der Schilden, Oene Zwaagstra, Niels J. Sijbrandi, Eugen Merkul and Guus A.M.S. van Dongen

Journal of Nuclear Medicine July 1, 2018, 59 (7) 1146-1151; DOI: https://doi.org/10.2967/jnumed.117.206672
You have access
Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
Amanda C. Freise, Kirstin A. Zettlitz, Felix B. Salazar, Richard Tavaré, Wen-Ting K. Tsai, Arion F. Chatziioannou, Nora Rozengurt, Jonathan Braun and Anna M. Wu

Journal of Nuclear Medicine June 1, 2018, 59 (6) 980-985; DOI: https://doi.org/10.2967/jnumed.117.199075
You have access
Long–Half-Life ⁸⁹Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of Radiotracer
Francois H. Cornelis, Jeremy C. Durack, Neeta Pandit-Taskar, Gary A. Ulaner, Jason S. Lewis, Michael J. Morris and Stephen B. Solomon

Journal of Nuclear Medicine March 1, 2018, 59 (3) 399-402; DOI: https://doi.org/10.2967/jnumed.117.194480

Main menu

User menu

Search

89Zr

Pages